[Is it advisable to produce anti-Rh0(D) immunoglobulin for the prevention of hemolytic disease of the newborn? (apropos the article by A. A. Mikhaĭlova and N. Ia. Klimova)].
N I
NI
Olovnikova
I L
IL
Chertkov
D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D007518:Isoantibodies / Q000302:isolation & purification* / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D012203:Rh Isoimmunization / Q000517:prevention & control; D012204:Rh-Hr Blood-Group System / Q000276:immunology*; D018029:Rho(D) Immune Globulin
D007518:Isoantibodies; C061961:RHO(D) antibody; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin
Tselesoobrazno li proizvodit' immunoglobulin anti-Rh0(D) dlia profilaktiki gemoliticheskoĭ bolezni novorozhdennykh? (po povodu stat'i A. A. Mikhaĭlovoĭ i N. Ia. Klimovoĭ).